{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:29:10Z","timestamp":1778506150625,"version":"3.51.4"},"reference-count":83,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1093\/jnci\/dju067","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T03:32:38Z","timestamp":1396582358000},"source":"Crossref","is-referenced-by-count":12,"title":["Multiple Myeloma in the Very Old: An IASIA Conference Report"],"prefix":"10.1093","volume":"106","author":[{"given":"Sascha A.","family":"Tuchman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary R.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Ershler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Badros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene Q.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bindu","family":"Kanapuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Jurivich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan L.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Nourbakhsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Walston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome W.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,4,3]]},"reference":[{"key":"key\n\t\t\t\t20170518235113_CIT0001","author":"United States Census Bureau"},{"key":"key\n\t\t\t\t20170518235113_CIT0002","author":"United Nations Department of Economic and Social Affairs, Population Division"},{"issue":"11","key":"key\n\t\t\t\t20170518235113_CIT0003","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1634\/theoncologist.2011-0229","article-title":"Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data","volume":"16","author":"Pulte","year":"2011","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t20170518235113_CIT0004","author":"National Cancer Institute"},{"issue":"22","key":"key\n\t\t\t\t20170518235113_CIT0005","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: Race-, sex-, and age-based disparities","volume":"291","author":"MVH, Krumholz HM, Gross CP.","year":"2004","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170518235113_CIT0006","volume-title":"Clinical Ethics: A Practical Approach to Ethical Decisions in Clinical Medicine","author":"Jonsen","year":"2002","edition":"5th"},{"issue":"21","key":"key\n\t\t\t\t20170518235113_CIT0007","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.285.21.2750","article-title":"Cancer screening in elderly patients: a framework for individualized decision making","volume":"285","author":"Walter","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"key\n\t\t\t\t20170518235113_CIT0008","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1200\/JCO.2001.19.4.1147","article-title":"Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base","volume":"19","author":"Yancik","year":"2001","journal-title":"J Clin Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170518235113_CIT0009","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jso.10160","article-title":"5- and 10-year survival in cancer patients aged 90 and older: a study of 37,318 patients from SEER","volume":"81","author":"Saltzstein","year":"2002","journal-title":"J Surg Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170518235113_CIT0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/107327480701400106","article-title":"Tolerance to chemotherapy in elderly patients with cancer","volume":"14","author":"Wedding","year":"2007","journal-title":"Cancer Control"},{"issue":"2","key":"key\n\t\t\t\t20170518235113_CIT0011","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.arr.2012.01.001","article-title":"Chronology of age-related disease definitions: osteoporosis and sarcopenia","volume":"11","author":"Bijlsma","year":"2012","journal-title":"Ageing Res Rev"},{"key":"key\n\t\t\t\t20170518235113_CIT0012","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.med.51.1.245","article-title":"Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty","volume":"51","author":"Ershler","year":"2000","journal-title":"Annu Rev Med"},{"issue":"7","key":"key\n\t\t\t\t20170518235113_CIT0013","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1046\/j.1532-5415.2001.49189.x","article-title":"High body mass index does not predict mortality in older people: analysis of the Longitudinal Study of Aging","volume":"49","author":"Grabowski","year":"2001","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"key\n\t\t\t\t20170518235113_CIT0014","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.arr.2007.08.004","article-title":"Dietary factors, hormesis and health","volume":"7","author":"Mattson","year":"2008","journal-title":"Ageing Res Rev"},{"issue":"6","key":"key\n\t\t\t\t20170518235113_CIT0015","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/ajcn\/77.6.1417","article-title":"Dietary patterns and changes in body mass index and waist circumference in adults","volume":"77","author":"Newby","year":"2003","journal-title":"AM J Clin Nutr"},{"issue":"3","key":"key\n\t\t\t\t20170518235113_CIT0016","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"key\n\t\t\t\t20170518235113_CIT0017","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0002-9343(02)01484-5","article-title":"Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly","volume":"114","author":"Cohen","year":"2003","journal-title":"Am J Med"},{"issue":"14","key":"key\n\t\t\t\t20170518235113_CIT0018","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1200\/JCO.2007.10.6559","article-title":"Comprehensive geriatric assessment for older patients with cancer","volume":"25","author":"Extermann","year":"2007","journal-title":"J Clin Oncol"},{"issue":"20","key":"key\n\t\t\t\t20170518235113_CIT0019","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.291.20.2441","article-title":"Prognostic importance of comorbidity in a hospital-based cancer registry","volume":"291","author":"Piccirillo","year":"2004","journal-title":"JAMA"},{"issue":"14","key":"key\n\t\t\t\t20170518235113_CIT0020","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1200\/JCO.2007.10.6559","article-title":"Comprehensive geriatric assessment for older patients with cancer","volume":"25","author":"Extermann","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170518235113_CIT0021","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.critrevonc.2005.06.003","article-title":"Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)","volume":"55","author":"Extermann","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"issue":"25","key":"key\n\t\t\t\t20170518235113_CIT0022","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170518235113_CIT0023","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbmt.2012.11.006","article-title":"Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients","volume":"19","author":"Muffly","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"key\n\t\t\t\t20170518235113_CIT0024","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer"},{"issue":"20","key":"key\n\t\t\t\t20170518235113_CIT0025","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/jnci\/89.20.1489","article-title":"Aging and cancer: issues of basic and clinical science","volume":"89","author":"Ershler","year":"1997","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"key\n\t\t\t\t20170518235113_CIT0026","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1111\/j.1532-5415.2008.01864.x","article-title":"Decreased cancer prevalence in the nursing home","volume":"56","author":"Kanapuru","year":"2008","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"key\n\t\t\t\t20170518235113_CIT0027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2141.2001.03043.x","article-title":"Prognostic significance of risk group stratification in elderly patients with acute myeloid leukaemia","volume":"115","author":"Wahlin","year":"2001","journal-title":"Br J Haematol"},{"issue":"14","key":"key\n\t\t\t\t20170518235113_CIT0028","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","year":"1993","journal-title":"New Engl J Med"},{"issue":"8","key":"key\n\t\t\t\t20170518235113_CIT0029","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrc1675","article-title":"Cancer and ageing: a nexus at several levels","volume":"5","author":"Balducci","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"key\n\t\t\t\t20170518235113_CIT0030","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"issue":"5","key":"key\n\t\t\t\t20170518235113_CIT0031","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1182\/blood-2007-08-104984","article-title":"Recent major improvement in long-term survival of younger patients with multiple myeloma","volume":"111","author":"Brenner","year":"2008","journal-title":"Blood"},{"issue":"8","key":"key\n\t\t\t\t20170518235113_CIT0032","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1182\/blood-2007-03-081018","article-title":"Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group","volume":"111","author":"Ludwig","year":"2008","journal-title":"Blood"},{"issue":"1","key":"key\n\t\t\t\t20170518235113_CIT0033","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"key\n\t\t\t\t20170518235113_CIT0034","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3324\/haematol.2012.075051","article-title":"Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials","volume":"98","author":"Bringhen","year":"2013","journal-title":"Haematologica"},{"issue":"15","key":"key\n\t\t\t\t20170518235113_CIT0035","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"issue":"21","key":"key\n\t\t\t\t20170518235113_CIT0036","first-page":"3972","article-title":"Continued improvement in survival in multiple myeloma and the impact of novel agents","volume":"120","author":"Kumar","year":"2012","journal-title":"ASH Ann Meeting Abstr"},{"issue":"9","key":"key\n\t\t\t\t20170518235113_CIT0037","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.leu.2403857","article-title":"Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma","volume":"19","author":"Ross","year":"2005","journal-title":"Leukemia"},{"issue":"30","key":"key\n\t\t\t\t20170518235113_CIT0038","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1200\/JCO.2010.28.3945","article-title":"Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p)","volume":"28","author":"Avet-Loiseau","year":"2010","journal-title":"J Clin Oncol"},{"issue":"22","key":"key\n\t\t\t\t20170518235113_CIT0039","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1200\/JCO.2012.46.2598","article-title":"Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du my\u00e9lome experience","volume":"31","author":"Avet-Loiseau","year":"2013","journal-title":"J Clin Oncol"},{"issue":"26","key":"key\n\t\t\t\t20170518235113_CIT0040","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa032290","article-title":"Single versus double autologous stem-cell transplantation for multiple myeloma","volume":"349","author":"Attal","year":"2003","journal-title":"New Engl J Med"},{"issue":"2","key":"key\n\t\t\t\t20170518235113_CIT0041","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma","volume":"335","author":"Attal","year":"1996","journal-title":"New Engl J Med"},{"issue":"19","key":"key\n\t\t\t\t20170518235113_CIT0042","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"key\n\t\t\t\t20170518235113_CIT0043","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2004-02-0408","article-title":"Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial","volume":"104","author":"Palumbo","year":"2004","journal-title":"Blood"},{"issue":"9594","key":"key\n\t\t\t\t20170518235113_CIT0044","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(07)61537-2","article-title":"Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial","volume":"370","author":"Facon","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"key\n\t\t\t\t20170518235113_CIT0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/10428194.2011.606942","article-title":"Feasibility of autologous hematopoietic stem cell transplant in patients aged \u226570 years with multiple myeloma","volume":"53","author":"Bashir","year":"2012","journal-title":"Leukemia Lymphoma"},{"issue":"8","key":"key\n\t\t\t\t20170518235113_CIT0046","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/ajh.21191","article-title":"Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: results from a matched pair analysis","volume":"83","author":"Kumar","year":"2008","journal-title":"Am J Hematol"},{"issue":"9","key":"key\n\t\t\t\t20170518235113_CIT0047","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1001\/jama.1969.03160090040009","article-title":"Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens","volume":"208","author":"Alexanian","year":"1969","journal-title":"JAMA"},{"issue":"21","key":"key\n\t\t\t\t20170518235113_CIT0048","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma","volume":"341","author":"Singhal","year":"1999","journal-title":"New Engl J Med"},{"issue":"4","key":"key\n\t\t\t\t20170518235113_CIT0049","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/leu.2010.313","article-title":"Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and\/or transplant ineligible patients with multiple myeloma: a meta-analysis","volume":"25","author":"Kapoor","year":"2011","journal-title":"Leukemia"},{"issue":"1","key":"key\n\t\t\t\t20170518235113_CIT0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3324\/haematol.2012.067058","article-title":"Safety of thalidomide in newly diagnosed elderly myeloma patients: an individual patient data meta-analysis of six randomized trials","volume":"98","author":"Palumbo","year":"2012","journal-title":"Haematologica"},{"issue":"5","key":"key\n\t\t\t\t20170518235113_CIT0051","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1182\/blood-2011-03-341669","article-title":"Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials","volume":"118","author":"Fayers","year":"2011","journal-title":"Blood"},{"issue":"9594","key":"key\n\t\t\t\t20170518235113_CIT0052","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(07)61537-2","article-title":"Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial","volume":"370","author":"Facon","year":"2007","journal-title":"Lancet"},{"issue":"22","key":"key\n\t\t\t\t20170518235113_CIT0053","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1200\/JCO.2008.21.0948","article-title":"Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01\/01 trial","volume":"27","author":"Hulin","year":"2009","journal-title":"J Clin Oncol"},{"issue":"8","key":"key\n\t\t\t\t20170518235113_CIT0054","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1182\/blood-2008-04-149427","article-title":"Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial","volume":"112","author":"Palumbo","year":"2008","journal-title":"Blood"},{"issue":"9","key":"key\n\t\t\t\t20170518235113_CIT0055","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood-2009-08-237974","article-title":"Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma","volume":"116","author":"Waage","year":"2010","journal-title":"Blood"},{"issue":"19","key":"key\n\t\t\t\t20170518235113_CIT0056","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1200\/JCO.2009.26.1610","article-title":"Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study","volume":"28","author":"Wijermans","year":"2010","journal-title":"J Clin Oncol"},{"issue":"26","key":"key\n\t\t\t\t20170518235113_CIT0057","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1182\/blood-2010-08-303487","article-title":"Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)","volume":"116","author":"Zonder","year":"2010","journal-title":"Blood"},{"issue":"1","key":"key\n\t\t\t\t20170518235113_CIT0058","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(09)70284-0","article-title":"Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial","volume":"11","author":"Rajkumar","year":"2010","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20170518235113_CIT0059","first-page":"S149","article-title":"Outcome of elderly patients 70 years and older with newly diagnosed myeloma in the ECOG randomized trial of lenalidomide\/high-dose dexamethasone (RD) versus lenalidomide\/low-dose dexamethasone (Rd)","volume":"95","author":"Jacobus","year":"2010","journal-title":"Haematologica"},{"issue":"19","key":"key\n\t\t\t\t20170518235113_CIT0060","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1056\/NEJMoa1112704","article-title":"Continuous lenalidomide treatment for newly diagnosed multiple myeloma","volume":"366","author":"Palumbo","year":"2012","journal-title":"New Engl J Med"},{"issue":"24","key":"key\n\t\t\t\t20170518235113_CIT0061","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","article-title":"Bortezomib or high-dose dexamethasone for relapsed multiple myeloma","volume":"352","author":"Richardson","year":"2005","journal-title":"New Engl J Med"},{"issue":"5","key":"key\n\t\t\t\t20170518235113_CIT0062","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2141.2007.06585.x","article-title":"Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma","volume":"137","author":"Richardson","year":"2007","journal-title":"Br J Haematol"},{"issue":"4","key":"key\n\t\t\t\t20170518235113_CIT0063","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.leu.2405087","article-title":"Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study","volume":"22","author":"San-Miguel","year":"2008","journal-title":"Leukemia"},{"issue":"13","key":"key\n\t\t\t\t20170518235113_CIT0064","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1200\/JCO.2009.26.0638","article-title":"Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial","volume":"28","author":"Mateos","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"key\n\t\t\t\t20170518235113_CIT0065","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1470-2045(11)70081-X","article-title":"Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study","volume":"12","author":"Moreau","year":"2011","journal-title":"Lancet Oncol"},{"issue":"23","key":"key\n\t\t\t\t20170518235113_CIT0066","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1182\/blood-2010-07-294983","article-title":"Efficacy and safety of once-weekly bortezomib in multiple myeloma patients","volume":"116","author":"Bringhen","year":"2010","journal-title":"Blood"},{"issue":"17","key":"key\n\t\t\t\t20170518235113_CIT0067","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1182\/blood-2011-06-358812","article-title":"Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)","volume":"118","author":"Palumbo","year":"2011","journal-title":"Blood"},{"issue":"21","key":"key\n\t\t\t\t20170518235113_CIT0068","first-page":"478","article-title":"Efficacy and safety of three bortezomib-based combinations in elderly, newly diagnosed multiple myeloma patients: results from all randomized patients in the community-based, phase 3b UPFRONT study","volume":"118","author":"Niesvizky","year":"2011","journal-title":"ASH Ann Meeting Abstr"},{"issue":"14","key":"key\n\t\t\t\t20170518235113_CIT0069","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1200\/JCO.2007.10.6583","article-title":"International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature","volume":"25","author":"Lichtman","year":"2007","journal-title":"J Clin Oncol"},{"issue":"8","key":"key\n\t\t\t\t20170518235113_CIT0070","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/annonc\/mdm011","article-title":"Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations","volume":"18","author":"Launay-Vacher","year":"2007","journal-title":"Ann Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170518235113_CIT0071","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.archger.2004.03.006","article-title":"Prevalence of anemia in skilled-nursing home residents","volume":"39","author":"Artz","year":"2004","journal-title":"Arch Gerontol Geriatr"},{"key":"key\n\t\t\t\t20170518235113_CIT0072","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.amjmed.2003.12.009","article-title":"Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature","volume":"116","author":"Beghe","year":"2004","journal-title":"Am J Med"},{"issue":"1","key":"key\n\t\t\t\t20170518235113_CIT0073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1040-8428(03)00093-3","article-title":"Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy","volume":"47","author":"Van Belle","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"issue":"33","key":"key\n\t\t\t\t20170518235113_CIT0074","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1200\/JCO.2010.29.2201","article-title":"American Society of Clinical Oncology\/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer","volume":"28","author":"Rizzo","year":"2010","journal-title":"J Clin Oncol"},{"issue":"124","key":"key\n\t\t\t\t20170518235113_CIT0075","first-page":"1","article-title":"Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications","volume":"12","author":"Briones","year":"2011","journal-title":"BMC Neurosci"},{"issue":"4","key":"key\n\t\t\t\t20170518235113_CIT0076","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2354.2011.01244.x","article-title":"\u201cChemobrain\u201d: concentration and memory effects in people receiving chemotherapy\u2014a descriptive phenomenological study","volume":"20","author":"Mitchell","year":"2011","journal-title":"Eur J Cancer Care"},{"issue":"1","key":"key\n\t\t\t\t20170518235113_CIT0077","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nutres.2010.12.001","article-title":"Prevalence and correlates of vitamin D deficiency in US adults","volume":"31","author":"Forrest","year":"2011","journal-title":"Nutr Res"},{"issue":"11","key":"key\n\t\t\t\t20170518235113_CIT0078","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1046\/j.1532-5415.2002.50503.x","article-title":"Factors associated with falls in older patients with diffuse polyneuropathy","volume":"50","author":"Richardson","year":"2002","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"key\n\t\t\t\t20170518235113_CIT0079","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1532-5415.1999.tb01898.x","article-title":"Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs","volume":"47","author":"Leipzig","year":"1999","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"key\n\t\t\t\t20170518235113_CIT0080","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood.V98.5.1614","article-title":"Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy","volume":"98","author":"Zangari","year":"2001","journal-title":"Blood"},{"issue":"7","key":"key\n\t\t\t\t20170518235113_CIT0081","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2009-08-239046","article-title":"Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients","volume":"115","author":"Gay","year":"2010","journal-title":"Blood"},{"issue":"1","key":"key\n\t\t\t\t20170518235113_CIT0082","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1523-5394.2001.91004.x","article-title":"Physical functioning and depression among older persons with cancer","volume":"9","author":"Kurtz","year":"2001","journal-title":"Cancer Pract"},{"issue":"6","key":"key\n\t\t\t\t20170518235113_CIT0083","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1037\/0278-6133.23.6.564","article-title":"A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate","volume":"23","author":"Stommel","year":"2004","journal-title":"Health Psychol"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/106\/5\/dju067\/13380140\/dju067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T06:04:36Z","timestamp":1565330676000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/dju067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,3]]},"references-count":83,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,4,3]]},"published-print":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/dju067","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4,3]]}}}